Cargando…

Antenatal corticosteroids and COVID-19: balancing benefits and harms

Detalles Bibliográficos
Autores principales:	Liauw, Jessica, Gundy, Serena, Rochwerg, Bram, Hutcheon, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446611/ https://www.ncbi.nlm.nih.gov/pubmed/32858012 http://dx.doi.org/10.1016/j.ajog.2020.08.062

Ejemplares similares

Counterpoint: The value of benchmarking in observational studies of the longer term safety of antenatal corticosteroids
por: Hutcheon, Jennifer A., et al.
Publicado: (2022)

Antenatal corticosteroid administration and early school age child development: A regression discontinuity study in British Columbia, Canada
por: Hutcheon, Jennifer A., et al.
Publicado: (2020)

Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
por: FakhriRavari, Alireza, et al.
Publicado: (2021)

Antenatal corticosteroid administration and attention-deficit/hyperactivity disorder in childhood: a regression discontinuity study
por: Hutcheon, Jennifer A., et al.
Publicado: (2022)

Antenatal corticosteroids may contribute to illness in children in the future
por: Casulari, Luiz Augusto, et al.
Publicado: (2022)

Understanding what patients and physicians need to improve their decision-making about antenatal corticosteroids in late preterm gestation: a qualitative framework analysis
por: Foggin, Hannah, et al.
Publicado: (2023)

Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
por: An, Tai Joon, et al.
Publicado: (2022)

Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2021)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Caution When Comparing the Impact of Corticosteroids in COVID-19
por: Confalonieri, Marco, et al.
Publicado: (2021)

COVID-19 and antenatal care: An update
por: Ncube, Mothusi Mncedisi
Publicado: (2021)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

Antenatal corticosteroids in COVID-19 perspective
por: Vidaeff, Alex C, et al.
Publicado: (2021)

Corticosteroids for severe community-acquired pneumonia: a story without an ending
por: Rochwerg, Bram
Publicado: (2022)

Impact of COVID-19 on antenatal care provision
por: Esegbona-Adeigbe, Sarah
Publicado: (2020)

A reappraisal of corticosteroids use for COVID-19
por: Pati, Ilaria, et al.
Publicado: (2022)

Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
por: Gharamti, Amal A., et al.
Publicado: (2021)

D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
por: Goh, Yihui, et al.
Publicado: (2021)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2020)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Should Fetal Growth Charts Be References or Standards?
por: Hutcheon, Jennifer A., et al.
Publicado: (2020)

Should Deep Brain Stimulation Programs Be Halted During the COVID-19 Pandemic? Balancing the Risk of COVID-19 Infection Against the Survival Benefits of DBS
por: Bara, Gregor A., et al.
Publicado: (2020)

Antenatal Care Utilization in Afghanistan during COVID-19: Challenges and Recommendations
por: Stanikzai, Muhammad Haroon
Publicado: (2022)

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

Harm of early dexamethasone for COVID-19 and bias in randomized trials
por: Núñez, Isaac, et al.
Publicado: (2023)

Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
por: Shokri, Somayeh, et al.
Publicado: (2022)

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022)

Sun Exposure in Children: Balancing the Benefits and Harms
por: Jindal, Ankur K., et al.
Publicado: (2020)

Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19
por: Kavsak, Peter A., et al.
Publicado: (2020)

Impact of COVID-19 pandemic on antenatal healthcare services in Sub-Saharan Africa
por: Ogunkola, Isaac Olushola, et al.
Publicado: (2021)

Colchicine may not be effective in COVID-19 infection; it may even be harmful?
por: Cumhur Cure, Medine, et al.
Publicado: (2020)

Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19
por: Kavanagh, Oisín, et al.
Publicado: (2020)

Non-recommended medical interventions and their possible harm in patients with COVID-19
por: Pecho-Silva, Samuel, et al.
Publicado: (2021)

Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids
por: John, Teny M., et al.
Publicado: (2020)

The association between corticosteroid uses and mortality among severe COVID-19 patients
por: Tang, Hung-Jen, et al.
Publicado: (2021)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33ktkj1456qm1pddc7mnkj0s1v